AFP and hepatocellular carcinoma: This was in agreement with the findings of Weiet al.16, who proved that AFP levels are significantly higher in patients with HCC in comparison to those with chronic liver disease (CLD) and healthy controls; they suggested that this increase is due to selective transcriptional activation of the AFP gene in the malignant hepatocytes.